Effect of sacubitril/valsartan on the occurrence of cardiac arrhythmias and the risk of sudden cardiac death in heart failure: A meta-analysis of randomized controlled trials

BACKGROUND: Sacubitril/valsartan therapy reduced the risks of death and of hospitalization for heart failure (HF). HF and cardiac arrhythmias have shared physiological mechanisems. Therefore, sacubitril/valsartan may exhibit anti-arrhythmic properties in HF. The purpose of this study was to evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xue-Hui, Wang, Guan-Ling, Xu, Qiang, Zhang, Lei, Liu, Hong-Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489142/
https://www.ncbi.nlm.nih.gov/pubmed/36148074
http://dx.doi.org/10.3389/fcvm.2022.943377

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489142/
https://www.ncbi.nlm.nih.gov/pubmed/36148074
http://dx.doi.org/10.3389/fcvm.2022.943377

Ejemplares similares